Roadmap &
Exchanges

Take a look at our journey ahead

Roadmap

Alpha 2.0 Release

100%

The latest advancements in the platform include avatars, issuing of notifications, bug-fixing throughout the platform, enterprise search functionality, an upgraded UI, and finally our blockchain transaction and verification for DNA file-uploading.

MVP

25%

The next release will set to deliver a marketplace with direct-to-consumer partners offering reports, services and kits, secure-sharing features with monetisation through smart contracts and a complete end-to-end solution for the enterprise end-user, from data discovery to reporting and analysis.

Marketplace 2.0

20%

Redeem tokens for products from our direct-to-consumer partners, from kits, reports to healthcare services. The new marketplace will provide users with the ability to utilise OMX earned from research purposes to improve their health and wellbeing.

Search 2.0

75%

Search de-identified data categorised by therapeutic area, disease and/or sub-type. This will be suitably supported by filters via country, gender, pre-existing conditions etc. through phenotypic data. Along with this, our platform will provide you with the ability to save the datasets and analyse them as per your convenience.

Analysis & Reporting 1.0

25%

With an automated, 24*7 real-time analysis of DNA data, our platform offers industry standard and custom pipelines on protected datasets (GWAS, Family Trios, PWAS, etc.). The results are powered by artificial intelligence via LifeBit integration and allow for rapid response rates.

Dynamic Consent 2.0

80%

Within our dynamic consent permissioning technology data owners and custodians may choose who comes in contact with their data. For example a patient support network, government agency or pharmaceutical company.

Medical Record 1.0

40%

Medical records will be replacing our “MyDNA” page and act as a secure way to upload various medical records. From genetic data to blood tests data owners and custodians have the ability to monetise and share any type of health and or omic data with researchers.

Notifications 1.0

90%

Through the introduction of our notifications system, end-users will be able to be notified when data has been used for research purposes and when receiving compensation from smart contracts.

Smart Contracts 1.0

50%

Our first iteration of using smart contracts will provide end-users with traceability throughout user journeys (permissions, data sharing etc.)

Enterprise Dashboard 1.0

60%

Search de-identified data categorised by therapeutic area, disease and/or sub-type. This will be suitably supported by filters via country, gender, pre-existing conditions etc. through phenotypic data. Along with this, our platform will provide you with the ability to save the datasets and analyse them as per your convenience.

2FA Security

65%

With 2FA security we’ve added an extra layer of protecting our end-users accounts. This is the first step of added authentication within our roadmap.

Exchanges